Ventyx Biosciences, Inc.

CIK 1851194 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ventyx Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2026SCHEDULE 13G/A0001214659-26-006497
May 14, 2026SCHEDULE 13G/A0001076809-26-000058
May 14, 2026SCHEDULE 13G/A0001011438-26-000315
Mar 16, 202615-12G0001193125-26-107754
Mar 6, 2026EFFECT9999999995-26-000741
Mar 6, 2026EFFECT9999999995-26-000740
Mar 5, 2026SCHEDULE 13D/A0000929638-26-000874
Mar 4, 202640001575202-26-000002
Mar 4, 2026POS AM0001193125-26-090533
Mar 4, 202640001878125-26-000002
Mar 4, 2026S-8 POS0001193125-26-090558
Mar 4, 202640001778739-26-000002
Mar 4, 202640001799355-26-000002
Mar 4, 20268-K0001193125-26-090059
Mar 4, 202640001840191-26-000002
Mar 4, 202640001508910-26-000004
Mar 4, 202640001922353-26-000002
Mar 4, 2026POS AM0001193125-26-090536
Mar 4, 202640001573886-26-000002
Mar 4, 202625-NSE0001354457-26-000227
Mar 4, 2026S-8 POS0001193125-26-090553
Mar 4, 2026S-8 POS0001193125-26-090544
Mar 4, 2026S-8 POS0001193125-26-090538
Mar 4, 202640001874108-26-000002
Mar 4, 202640002035970-26-000002